approval
saveSIMPONI (GOLIMUMAB) — FDA approval
October 1, 2025updated 5mo ago
community read0 votes
Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalteclistamab: TECVAYLI (TECLISTAMAB-CQYV) — FDA approvalOct 2, 2025
- approvaltalquetamab: TALVEY (TALQUETAMAB-TGVS) — FDA approvalOct 2, 2025
- approvalguselkumab: TREMFYA (GUSELKUMAB) — FDA approvalSep 26, 2025
- approvalguselkumab: TREMFYA (GUSELKUMAB) — FDA approvalSep 26, 2025
- approvalSIMPONI (GOLIMUMAB) — FDA approvalOct 7, 2025
- approvalamivantamab: RYBREVANT (AMIVANTAMAB-VMJW) — FDA approvalOct 8, 2025
🐶 often sniffed alongside
top 8- tagApproval214 co-mentions · 107 sources
- tagSmall Molecule32 co-mentions · 32 sources
- drugERLEADA30 co-mentions · 15 sources
- drugdaratumumab + Gene Therapy30 co-mentions · 15 sources
- drugapalutamide30 co-mentions · 15 sources
- drugDARZALEX FASPRO30 co-mentions · 15 sources
- drugdaratumumab30 co-mentions · 15 sources
- drugustekinumab28 co-mentions · 14 sources
comments(0)
5-min edit window · permanent after that